6.10 Respiratory Viral Infections
Overview
Influenza, COVID-19, and respiratory syncytial virus (RSV) represent three significant respiratory illnesses that have garnered global attention due to their contagious nature and potential for severe health complications. Influenza, commonly known as the flu, is caused by influenza viruses that primarily infect the respiratory tract, leading to symptoms such as fever, cough, sore throat, body aches, and fatigue. COVID-19, caused by the novel coronavirus SARS-CoV-2, emerged as a global pandemic in late 2019, causing a wide spectrum of symptoms, ranging from mild respiratory distress to severe pneumonia and organ failure. RSV, a common cause of respiratory infections in infants and young children, is characterized by symptoms similar to the common cold, including coughing, sneezing, and fever.[1]
Pathophysiology
Each pathogen has distinct pathophysiological mechanisms, but they share a commonality in targeting the respiratory system, often leading to inflammation, tissue damage, and compromised lung function. Understanding the pathophysiology behind these illnesses is crucial for developing effective preventive measures and treatment strategies to mitigate their impact on public health.
Influenza viruses primarily target epithelial cells lining the respiratory tract. The virus enters the body through inhalation of respiratory droplets or contact with contaminated surfaces. Once inside the respiratory tract, the virus attaches to specific receptors on the surface of epithelial cells, facilitating viral entry and replication. This process triggers an inflammatory response characterized by the release of cytokines and chemokines, which recruit immune cells to the site of infection.[2]
COVID-19 is caused by the novel coronavirus SARS-CoV-2. Similar to influenza, SARS-CoV-2 enters the body through the respiratory tract via inhalation or contact with contaminated surfaces. The virus primarily targets cells expressing angiotensin-converting enzyme 2 (ACE2) receptors, which are abundant in the respiratory epithelium. Upon infection, SARS-CoV-2 attacks host cellular machinery to replicate, leading to the release of viral particles and cell damage. This triggers a dysregulated immune response characterized by the production of pro-inflammatory cytokines and chemokines, often referred to as a cytokine storm. The resulting inflammation and immune dysregulation contribute to the wide spectrum of symptoms observed in COVID-19, ranging from mild respiratory symptoms to severe pneumonia and acute respiratory distress syndrome (ARDS).[3]
Respiratory syncytial virus (RSV) primarily infects the respiratory epithelium, particularly in the lower airways. The virus enters the body through inhalation of respiratory secretions or contact with contaminated surfaces. RSV infects ciliated epithelial cells, leading to cell fusion and the formation of multinucleated syncytia, a hallmark of RSV infection. This process disrupts the int